The US pharmaceutical industry has called for the reversal of a judicial ruling that could withdraw regulatory approval for a common abortion drug, arguing that the judgment would diminish the authority of government agencies and put the industry at risk.
美国制药业呼吁撤销一项司法裁决，这项裁决可能使对一种常见堕胎药物的监管批准被撤回，美国制药业认为该裁决将削弱政府机构的权威，并将该行业置于风险之中。
您已阅读6%（329字），剩余94%（4886字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。